BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23409016)

  • 1. Photofrin based photodynamic therapy and miR-99a transfection inhibited FGFR3 and PI3K/Akt signaling mechanisms to control growth of human glioblastoma In vitro and in vivo.
    Chakrabarti M; Banik NL; Ray SK
    PLoS One; 2013; 8(2):e55652. PubMed ID: 23409016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the p53 tumor suppressor in the response of human cells to photofrin-mediated photodynamic therapy.
    Tong Z; Singh G; Rainbow AJ
    Photochem Photobiol; 2000 Feb; 71(2):201-10. PubMed ID: 10687395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 regulates human AlkB homologue 2 expression in glioma resistance to Photofrin-mediated photodynamic therapy.
    Lee SY; Luk SK; Chuang CP; Yip SP; To SS; Yung YM
    Br J Cancer; 2010 Jul; 103(3):362-9. PubMed ID: 20661249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells.
    Hajri A; Wack S; Meyer C; Smith MK; Leberquier C; Kedinger M; Aprahamian M
    Photochem Photobiol; 2002 Feb; 75(2):140-8. PubMed ID: 11883602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis.
    Zhang R; Banik NL; Ray SK
    Neurochem Res; 2007 Dec; 32(12):2194-202. PubMed ID: 17616812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants of photodynamic therapy for lung cancers.
    Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
    Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways.
    Oneyama C; Ikeda J; Okuzaki D; Suzuki K; Kanou T; Shintani Y; Morii E; Okumura M; Aozasa K; Okada M
    Oncogene; 2011 Aug; 30(32):3489-501. PubMed ID: 21383697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct transfection of miR-137 mimics is more effective than DNA demethylation of miR-137 promoter to augment anti-tumor mechanisms of delphinidin in human glioblastoma U87MG and LN18 cells.
    Chakrabarti M; Ray SK
    Gene; 2015 Nov; 573(1):141-52. PubMed ID: 26187071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the stress-activated JNK and p38 MAP kinases in human cells by Photofrin-mediated photodynamic therapy.
    Tong Z; Singh G; Valerie K; Rainbow AJ
    J Photochem Photobiol B; 2003 Oct; 71(1-3):77-85. PubMed ID: 14705642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
    Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
    Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy.
    Tong Z; Singh G; Rainbow AJ
    Cancer Res; 2002 Oct; 62(19):5528-35. PubMed ID: 12359764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-99a promotes proliferation targeting FGFR3 in human epithelial ovarian cancer cells.
    Jiang H; Qu L; Wang Y; Cong J; Wang W; Yang X
    Biomed Pharmacother; 2014 Mar; 68(2):163-9. PubMed ID: 24456664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF-2 Attenuates Neuronal Apoptosis via FGFR3/PI3k/Akt Signaling Pathway After Subarachnoid Hemorrhage.
    Okada T; Enkhjargal B; Travis ZD; Ocak U; Tang J; Suzuki H; Zhang JH
    Mol Neurobiol; 2019 Dec; 56(12):8203-8219. PubMed ID: 31203572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets.
    Hsieh YJ; Wu CC; Chang CJ; Yu JS
    J Cell Physiol; 2003 Mar; 194(3):363-75. PubMed ID: 12548556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
    Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild-type and mutant p53 differentially modulate miR-124/iASPP feedback following pohotodynamic therapy in human colon cancer cell line.
    Liu K; Chen W; Lei S; Xiong L; Zhao H; Liang D; Lei Z; Zhou N; Yao H; Liang Y
    Cell Death Dis; 2017 Oct; 8(10):e3096. PubMed ID: 29022915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy.
    Domagala A; Stachura J; Gabrysiak M; Muchowicz A; Zagozdzon R; Golab J; Firczuk M
    BMC Cancer; 2018 Feb; 18(1):210. PubMed ID: 29463237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.